Zydus Lifesciences aims for double-digit revenue growth over five years
The Economic Times reports that Zydus plans to focus on specialty medicines and biotechnology, with contributions from discovery-led products expected from 2030 onward.
TLDR
In reporting shared on September 24, 2026, The Economic Times says Zydus Lifesciences aims for double-digit revenue growth and improved profitability over the next five years. The company plans to strengthen its cancer-treatment business and explore partnerships for novel biologic medicines. Contributions from discovery-led products are expected from 2030 onward.
Combined views
7.5K
2 Sources, first seen ago